Laboratory reference method result | Titres | Syphilis history | T pallidum RDTs result on serum* | T pallidum RDTs result on blood* | |||||||||||||||
ID | CLIA | TPPA | RPR | TPPA | RPR | SD Bioline | Chembio T | Chembio NT | SD Bioline | Chembio T | Chembio NT | ||||||||
Reader 1 | Reader 2 | Reader 1 | Reader 2 | Reader 1 | Reader 2 | Reader 1 | Reader 2 | Reader 1 | Reader 2 | Reader 1 | Reader 2 | ||||||||
Part A (RPR-positive) | 1 | + | + | + | 20 480 | 128 | Pos | R | R | R | R | R | R | R | R | R | R | R | R |
2 | + | + | + | 20 480 | 128 | Neg | R | R | R | R | R | R | R | R | R | R | R | R | |
3 | + | + | + | 20 480 | 32 | Neg | R | R | R | R | R | R | R | R | R | R | R | R | |
4 | + | + | + | 20 480 | 16 | Neg | R | R | . | . | . | . | NR | R | . | . | . | . | |
5 | + | + | + | 10 240 | 16 | Pos | R | R | . | . | . | . | R | R | . | . | . | . | |
6 | + | + | + | 5120 | 16 | Neg | R | R | . | . | . | . | R | R | . | . | . | . | |
7 | + | + | + | 20 480 | 16 | Neg | R | R | R | R | R | R | R | R | R | R | R | R | |
8 | + | + | + | 20 480 | 8 | Pos | R | R | R | R | R | R | R | R | R | R | R | R | |
9 | + | + | + | 10 240 | 8 | Neg | R | R | R | R | R | R | R | R | R | R | R | R | |
10 | + | + | + | 20 480 | 4 | Pos | R | R | R | R | NR | NR | R | R | R | R | NR | NR | |
11 | + | + | + | 20 480 | 4 | Neg | R | R | R | R | NR | NR | R | R | R | R | NR | NR | |
12 | + | + | + | 5120 | 4 | Neg | R | R | R | R | R | R | R | R | R | R | R | R | |
13 | + | + | + | 5120 | 2 | Neg | R | R | . | . | . | . | NR | NR | . | . | . | . | |
14 | + | + | + | 20 480 | 2 | Neg | R | R | R | R | NR | NR | R | R | R | R | NR | NR | |
15 | + | + | + | 10 240 | 1 | Pos | R | R | . | . | . | . | R | R | . | . | . | . | |
16 | + | + | + | 10 240 | 1 | Pos | R | R | . | . | . | . | R | R | . | . | . | . | |
Part B (RPR-negative) | 1 | + | + | – | 10 240 | 0 | Pos | R | R | R | R | NR | NR | R | R | R | R | NR | NR |
2 | + | + | – | 10 240 | 0 | Pos | R | R | R | R | NR | NR | R | R | R | R | NR | NR | |
3 | + | + | – | 5120 | 0 | Neg | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
4 | + | + | – | 5120 | 0 | Pos | R | R | . | . | . | . | NR | NR | . | . | . | . | |
5 | + | + | – | 2560 | 0 | Pos | R | R | R | R | NR | NR | R | R | R | R | NR | NR | |
6 | + | + | – | 1280 | 0 | Pos | NR | R | NR | R | NR | R | NR | NR | R | R | NR | NR | |
7 | + | + | – | 1280 | 0 | Pos | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
8 | + | + | – | 640 | 0 | Pos | R | R | R | R | NR | NR | NR | NR | R | R | NR | NR | |
9 | + | + | – | 640 | 0 | Neg | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
10 | + | + | – | 640 | 0 | Pos | R | R | NR | . | NR | . | R | NR | R | R | NR | NR | |
11 | + | + | – | 640 | 0 | Neg | R | R | . | . | . | . | NR | NR | . | . | . | . | |
12 | + | + | – | 640 | 0 | Pos | R | R | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
13 | + | + | – | 320 | 0 | Pos | R | R | . | . | . | . | NR | NR | . | . | . | . | |
14 | + | + | – | 320 | 0 | Neg | R | R | R | R | NR | NR | NR | NR | NR | NR | NR | NR | |
15 | + | + | – | 160 | 0 | Pos | R | R | NR | NR | NR | NR | NR | R | NR | R | NR | NR | |
16 | + | + | – | 160 | 0 | Pos | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
17 | + | + | – | 160 | 0 | Pos | R | R | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
18 | + | + | – | 80 | 0 | Neg | NR | NR | NR | NR | NR | NR | NR | NR | R | R | NR | NR | |
19 | + | + | – | 80 | 0 | Pos | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR |
* Grey boxes indicate discordant results between RDT and reference test.
‘.’ indicates missing test (Chembio DPP Syphilis Screen & Confirm Assay expired during the study, therefore they were used only in a subsample of men who have sex with men).
Neg, negative; NT, non-treponemal test; NR, no reactive; Pos, positive; R, reactive, RDTs, rapid diagnostic tests; T, treponemal test.